Episodes: 125
Frequency: Every two weeks
Rating: 5.0/5.0
Estimated listeners: 100 - 1,000
Listener location: USA
YouTube: 282 subscribers
Instagram: 984 followers
Publicly listed emails
samira@mantacares.com
Looking for the right person? Join Podseeker to find direct host and producer contacts and manage your podcast outreach.
Samira Daswani - Cancer survivor, patient advocate, founder of Manta Cares, and host focused on helping people navigate cancer care and treatment.
Janice Cowden - Patient-centered Research, Metastatic Triple-negative Breast Cancer, Clinical-trial Design, Progression-free Survival, Treatment Sequencing, And Patient Involvement In Research.
Eugene Manley Jr., PhD - Health Equity In Cancer Research, Racial Representation In Cell Lines And Reference Genomes, Clinical-trial Diversity, Biomarker Testing, Patient Navigation, And Medical Advocacy.
Sara M. Tolaney, MD, MPH - First-line Treatment For Metastatic Triple-negative Breast Cancer, Antibody-drug Conjugates, Immunotherapy, Clinical-trial Findings, Tumor Sequencing, And Treatment Decision-making.
Shira Kupperman Boehler - Early Lung Cancer Detection, Screening Access, Lung Cancer Stigma, Insurance And Healthcare Access, Policy Reform, Artificial Intelligence In Screening, And Patient Advocacy.
Natalie Brown - Living With Metastatic Lung Cancer, Clinical Trials, Treatment Recurrence, Rare Transplant Procedures, Chronic Pain, Mental Health, And Patient Advocacy.
First-Line Treatment for Metastatic TNBC: Inside the ASCENT-03 Trial | Dr. Alissa Huston, University of Rochester
October 07, 2026
This episode is sponsored by Gilead Sciences. Gilead had no involvement or input in the podcast content. Gilead is working to transform how cancer is treated. We are innovating with next-generation therapies, combinations, and technologies to deliver improved outcomes for people with cancer. From antibody drug conjugates and small molecules to cell therapy-based approaches, our portfolio and pipeline assets are creating new possibilities for people with cancer.UPDATE SINCE RECORDING JANUARY 2...
The Genetic Test Every Patient Should Have Before 5-FU Chemotherapy | Dr. Gabe Brooks
September 30, 2026
Two of the most widely used chemotherapy drugs in the world, 5-FU and capecitabine, have been in use since the 1950s. A small share of patients carry variants in a gene called DPYD that slow their ability to break these drugs down, which means a standard dose behaves like an overdose in their body.A single genetic test can identify those patients before the first treatment. Europe recommended universal screening in 2020. The FDA updated the labels for both drugs in 2025, after years of pressu...
What Patient-Centered Research Looks Like, From a Nurse Who Became the Patient | Janice Cowden
September 16, 2026
This episode is sponsored by Gilead Sciences. Gilead had no involvement or input in the podcast content. Gilead is working to transform how cancer is treated. We are innovating with next-generation therapies, combinations, and technologies to deliver improved outcomes for people with cancer. From antibody drug conjugates and small molecules to cell therapy-based approaches, our portfolio and pipeline assets are creating new possibilities for people with cancer.Recorded on location at the San ...
Patient from Hell is hosted by Samira Daswani. Its publicly listed email is samira@mantacares.com. For guest bookings, the host or producer is usually the best person to reach. Podseeker helps you find direct host and producer contacts and pitch from your own inbox.
The publicly listed email for Patient from Hell: samira@mantacares.com.
Podseeker estimates Patient from Hell reaches 100 to 1,000 listeners per episode. Only the publisher has exact numbers.
Patient from Hell typically books industry leaders. Typical guest background: Oncology physicians and researchers, clinical-trial leaders, biomedical scientists, health-equity experts, patient advocates, cancer survivors, and founders of cancer-focused organizations. Strong candidates bring recognized clinical or research expertise, meaningful advocacy leadership, or a distinctive lived experience with practical lessons for patients. Common among recent guests: Leadership of oncology divisions or major cancer research programs; Principal-investigator or peer-reviewed clinical research experience; Founding or leading cancer advocacy and health-equity organizations. Recent guests include Janice Cowden, Eugene Manley Jr., PhD, and Sara M. Tolaney, MD, MPH.
Medium. Guests usually need solid credentials in the topic and an idea that fits the show.
Recent episodes cover Health, Oncology, Patient Advocacy, Clinical Trials, and Lung Cancer. Pitch an idea tied to one of these topics and mention a recent episode.
Publicly listed emails
samira@mantacares.com
Looking for the right person? Join Podseeker to find direct host and producer contacts and manage your podcast outreach.
Try us risk free with a FREE 3 days trial.
Join hundreds of PR teams using Podseeker to pitch and land bookings